This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
2
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Stifel analyst Dae Gon Ha downgraded the rating for Editas Medicine, Inc. (NASDAQ:EDIT) from Buy to Hold and lowered the price target from $11 to $3. Editas Medicine shares closed at $1.89 on Thursday. See how other analysts view this stock.
- Mizuho analyst Siti Panigrahi downgraded the rating for RingCentral, Inc. (NYSE:RNG) …
Full story available on Benzinga.com
Visited 2 times, 1 visit(s) today